NEOGENOMICS INC - 8-K Filing
NeoGenomics Inc. filed to report the results of its May 21, 2026 annual stockholder meeting where shareholders approved a second amendment increasing the share reserve in the company's 2023 Equity Incentive Plan by 5 million shares and elected nine directors with over 89% voting participation. Shareholders also approved advisory executive compensation (83% for) and ratified Deloitte & Touche LLP as auditors.
Tickers: $NEO